Search

Author/Creator Armuzzi, A

2. P802 Perforating Crohn's Disease and pancolitis as risk factors for incident cancer: a prospective multi-centre nested case–control IG-IBD study at 6 years. (25th January 2019)

Authors:
Petruzziello, C; Armuzzi, A; Scribano, M L; Castiglione, F; D'incà, R; Daperno, M; Papi, C; Vecchi, M; Fries, W; Riegler, G; Alvisi, P; Mocciaro, F; Neri, B; Festa, S; Testa, A; Calabrese, E; Di Mitri, R; De Crstofaro, E; Gesuale, C; Spina, L
Journal:
Journal of Crohn's and colitis
Issue:
Volume 13(2019)Supplement 1
Page Start:
S523
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. P256 Bowel contrast-enhanced ultrasound perfusion imaging in the evaluation of Crohn's disease patients. (25th January 2019)

Authors:
Laterza, L; Ainora, M E; Garcovich, M; Poscia, A; Lupascu, A; Riccardi, L; Scaldaferri, F; Armuzzi, A; Gasbarrini, A; Rapaccini, G L; Pompili, M; Zocco, M A
Journal:
Journal of Crohn's and colitis
Issue:
Volume 13(2019)Supplement 1
Page Start:
S225
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. P252 Measuring the mediating effects of Mayo score components for tofacitinib on disease-specific quality of life in ulcerative colitis: data from the OCTAVE programme. (25th January 2019)

Authors:
Dubinsky, M; Bushmakin, A; DiBonaventura, M; Cappelleri, J; Salese, L; Maller, E; Armuzzi, A
Journal:
Journal of Crohn's and colitis
Issue:
Volume 13(2019)Supplement 1
Page Start:
S222
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. P432 Barriers to prescribing anti-TNF therapy in inflammatory bowel disease (IBD) across newly industrialised emerging market countries: an analysis of the 'EXPLORE' study. (25th January 2019)

Authors:
Ye, B D; Yamamoto Furusho, J K; Rana Qasim Khan, M; Fadeeva, O; Demuth, D; Qian, J; Khalif, I L; Chia-Hung, T; Toruner, M; Othman, A H; Chan, W; Ponce de Leon, E; Guennec, M; Sison, C; Uberti Foppa, E; Armuzzi, A
Journal:
Journal of Crohn's and colitis
Issue:
Volume 13(2019)Supplement 1
Page Start:
S324
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. P801 Physicians' knowledge and application of immunisation strategies in patients with inflammatory bowel disease: a survey by the Italian Group for the study of inflammatory bowel disease (IG-IBD). (25th January 2019)

Authors:
Macaluso, F S; Mazzola, G; Ventimiglia, M; Alvisi, P; Renna, S; Adamoli, L; Galli, M; Armuzzi, A; Ardizzone, S; Cascio, A; Cottone, M; Orlando, A
Journal:
Journal of Crohn's and colitis
Issue:
Volume 13(2019)Supplement 1
Page Start:
S521
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. A68 COST EFFECTIVENESS OF TIGHT CONTROL FOR CROHN'S DISEASE WITH ADALIMUMAB-BASED TREATMENT: ECONOMIC EVALUATION OF CALM TRIAL FROM CANADIAN PERSPECTIVE. (15th March 2019)

Authors:
Panaccione, R; Colombel, J; Bossuyt, P; Baert, F; Vanasek, T; Danalioglu, A; Novacek, G; Armuzzi, A; Reinisch, W; Johnson, S; Buessing, M; Neimark, E; Petersson, J; Robinson, A M; Thakkar, R B; Lee, W; Skup, M; D'Haens, G
Journal:
Journal of the Canadian Association of Gastroenterology
Issue:
Volume 2(2019)Supplement 2
Page Start:
136
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. P685 Improvement in patient-reported Inflammatory Bowel Disease Questionnaire outcomes, and relationship with disease activity, in tofacitinib-treated patients with ulcerative colitis: Data from the OCTAVE clinical trials. (25th January 2019)

Authors:
Dubinsky, M C; Bressler, B; Armuzzi, A; Salese, L; DiBonaventura, M; Maller, E; Fan, H; Woodworth, D A; Su, C
Journal:
Journal of Crohn's and colitis
Issue:
Volume 13(2019)Supplement 1
Page Start:
S462
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗